Opus Genetics gets FDA Fast Track designation for Phentolamine Ophthalmic Solution
Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75%, reported ...
manilatimes20h
Vera Bradley, Inc. Announces Reporting Date for Fourth Quarter and Fiscal Year 2025 Results
FORT WAYNE, Ind., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vera Bradley, Inc. (Nasdaq: VRA) (the "Company”) today announced that it ...
Opus Genetics gets Fast Track designation for phentolamine ophthalmic solution
Opus Genetics (IRD) announced completion of enrollment in the VEGA-3 Phase 3 clinical trial evaluating Phentolamine Ophthalmic Solution 0.75% ...
Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night ...
Fox 135d
Pinellas mother of boy with rare metabolic disorder pushes for more accessible medical food
A Pinellas County mom is pushing for more accessible medical food for her 4-year-old son diagnosed with a rare metabolic ...
Finanznachrichten8d
Opus Genetics, Inc.: Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist being investigated to reduce pupil size, and APX3330, a novel ...
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...
Psychology Today24d
Why Many Men Avoid the Most Effective Erection Drugs
Few men use the most effective erection drugs because they must be self-injected into the penis. Few men are willing, but those who do usually like the results.